Related Experiment Video
Updated: Dec 13, 2025
14:32
Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
8.5K
Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target
Jin Zhang1, Honggang Xiang1, Jie Liu1
1State Key Laboratory of Biotherapy and Cancer Center and Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu 610041, China.
Theranostics
|July 30, 2020
Summary
Sirtuin 3 (SIRT3) is a key mitochondrial deacetylase regulating metabolism and homeostasis. Research highlights its role in diseases and potential as a therapeutic target for drug discovery.
Area of Science:
- Mitochondrial biology
- Enzymology
- Molecular medicine
Background:
- Sirtuin 3 (SIRT3) is a major mitochondrial deacetylase regulating cellular metabolism and homeostasis.
- SIRT3 plays a crucial role in protecting mitochondria from various forms of damage.
- Dysregulation of SIRT3 is implicated in numerous human diseases, including aging, cancer, and metabolic disorders.
Purpose of the Study:
- To summarize the complex mechanisms of SIRT3 in human diseases.
- To review recent advancements in small-molecule modulators targeting SIRT3.
- To discuss the therapeutic potential of SIRT3-targeting agents in drug discovery.
Main Methods:
- Literature review of SIRT3 function and disease association.
- Analysis of research on small-molecule activators and inhibitors of SIRT3.
- Synthesis of findings on therapeutic applications and future drug development.
Main Results:
- SIRT3 is integral to mitochondrial function, impacting diverse metabolic pathways.
- Evidence links SIRT3 to the pathogenesis of age-related, cancerous, cardiac, and metabolic diseases.
- Development of small-molecule SIRT3 modulators shows promise for therapeutic intervention.
Conclusions:
- SIRT3 is a critical regulator of mitochondrial health and a significant factor in human disease.
- Targeting SIRT3 with small molecules represents a promising avenue for novel therapeutic strategies.
- Further research into SIRT3 modulators could lead to effective treatments for various diseases.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
17.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
17.9K
01:37Mitochondria
18.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
18.9K
01:45Mitochondrial Membranes
16.1K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.1K
01:19Translocation of Proteins into the Mitochondria
11.5K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
11.5K
03:03mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K